Composition
- Active ingredients
- DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE EQ 50MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA212527.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Dolutegravir Lamivudine Tenofovir Alafenamide
- Dosage form
- Tablet
- Applicant
- Cipla USA Inc.
- Status
- Tentative approval
- FDA approval
- 30 Mar 2022
- Application
- NDA212527-001